[Hiring] Vice President Market Access & Value @Neurogene, Inc.

Role Description

Neurogene is seeking an accomplished, strategic, and entrepreneurial Vice President of Market Access and Value to lead the development and execution of its U.S. market access strategy as the company advances toward commercialization of innovative gene therapies for patients with rare neurological diseases. Reporting to the Chief Commercial Officer, this executive will play a critical role in preparing Neurogene for the potential launch of NGN-401, an investigational gene therapy for Rett syndrome, while establishing scalable market access capabilities to support the company's broader pipeline.

The Vice President will be responsible for developing comprehensive strategies across:

• Payer engagement
• Reimbursement
• Government programs
• Institutional access
• Contracting
• Value demonstration

A central priority will be addressing the unique economic, operational, and reimbursement complexities associated with high-cost, potentially one-time gene therapies administered at specialized treatment centers.

The ideal candidate brings a successful track record in rare disease commercialization, a sophisticated understanding of the evolving cell and gene therapy reimbursement landscape, and demonstrated ability to translate complex market access challenges into actionable strategies that enable patient access.

This is a unique opportunity to shape the market access foundation of an emerging gene therapy company at a pivotal stage of development.

Qualifications

• Bachelor's degree in business, life sciences, healthcare, economics, or a related field.
• Advanced degree in business, healthcare, public health, economics, or a related discipline is a plus.
• 15+ years of progressive leadership experience in pharmaceutical or biotechnology market access.
• Proven success supporting the launch and commercialization of rare disease, orphan, or highly specialized therapies.
• Deep understanding of the U.S. healthcare reimbursement environment.
• Demonstrated expertise in institutional reimbursement, hospital economics, coding and payment pathways.
• Experience developing payer value propositions and collaborating on HEOR and evidence-generation strategies.
• Strong strategic, analytical, financial, and communication skills.

Requirements

• Develop and execute an integrated U.S. market access strategy supporting the successful commercialization of NGN-401 and future Neurogene therapies.
• Serve as the company's senior market access expert, providing strategic guidance on payer dynamics and reimbursement pathways.
• Partner closely with Commercial, Medical Affairs, Finance, Regulatory, Legal, and other functional leaders.
• Lead the development and execution of comprehensive payer access strategies across commercial insurers, Medicaid, and other relevant government programs.
• Establish strategic relationships with key payer decision makers and government program stakeholders.
• Lead the development and execution of institutional reimbursement strategies designed to support specialized treatment centers.
• Partner with Commercial leadership and Finance to inform product pricing strategy.
• Partner with Medical Affairs to develop an integrated value evidence strategy.
• Build and lead a high-performing, scalable Market Access organization.

Benefits

• Opportunity to establish a critical commercial capability.
• Influence Neurogene's long-term commercialization strategy.
• Contribute meaningfully to the company's mission of bringing innovative therapies to patients.

Company Description

The mission of Neurogene is to treat devastating neurological diseases to improve the lives of patients and families impacted by these rare diseases. Neurogene is developing novel approaches and treatments to address the limitations of conventional gene therapy in central nervous system disorders.

Neurogene has constructed a state-of-the-art gene therapy manufacturing facility in Houston, Texas. This transformative work is driven by our highly collaborative people who come together each day to bring us closer to achieving our mission.